TABLE 7.
During | PT | a | ROR | ROR (95%Cl) |
---|---|---|---|---|
VOMITING PROJECTILE | 11 | 54.44 | 54.44 (30.09–98.52) | |
KETOSIS | 3 | 44.82 | 44.82 (14.42–139.36) | |
ERUCTATION | 37 | 28.47 | 28.47 (20.59–39.36) | |
FOOD AVERSION | 3 | 26.18 | 26.18 (8.43–81.31) | |
VITREOUS HAEMORRHAGE | 5 | 22.71 | 22.71 (9.44–54.64) | |
EUGLYCAEMIC DIABETIC KETOACIDOSIS | 5 | 20.45 | 20.45 (8.5–49.19) | |
DIABETIC RETINOPATHY | 5 | 18.5 | 18.5 (7.69–44.49) | |
4 weeks | VITREOUS DETACHMENT | 3 | 17.77 | 17.77 (5.72–55.17) |
PHARYNGEAL SWELLING | 9 | 14.45 | 14.45 (7.51–27.81) | |
DIABETIC KETOACIDOSIS | 27 | 14.22 | 14.22 (9.74–20.76) | |
NECK MASS | 3 | 13.38 | 13.38 (4.31–41.54) | |
IMPAIRED GASTRIC EMPTYING | 8 | 13.11 | 13.11 (6.55–26.24) | |
ILEUS PARALYTIC | 4 | 11.47 | 11.47 (4.3–30.59) | |
HYPERAESTHESIA | 8 | 11.43 | 11.43 (5.71–22.87) | |
PANCREATIC DISORDER | 4 | 10.92 | 10.92 (4.1–29.12) | |
MEDULLARY THYROID CANCER | 6 | 410.24 | 410.24 (182.31–923.15) | |
OBSTRUCTIVE PANCREATITIS | 4 | 155.15 | 155.15 (57.92–415.59) | |
ALLODYNIA | 4 | 98.06 | 98.06 (36.67–262.22) | |
FOOD AVERSION | 5 | 65.61 | 65.61 (27.24–158.03) | |
PANCREATITIS CHRONIC | 7 | 57.28 | 57.28 (27.25–120.41) | |
PANCREATIC CARCINOMA METASTATIC | 8 | 50.1 | 50.1 (25.01–100.38) | |
PAPILLARY THYROID CANCER | 4 | 45.59 | 45.59 (17.07–121.7) | |
>4 weeks | MACULAR HOLE | 3 | 42.43 | 42.43 (13.66–131.82) |
CHOLECYSTITIS INFECTIVE | 6 | 41.88 | 41.88 (18.78–93.38) | |
ADENOCARCINOMA PANCREAS | 3 | 41.02 | 41.02 (13.2–127.44) | |
BILIARY COLIC | 7 | 38.79 | 38.79 (18.46–81.51) | |
IMPAIRED GASTRIC EMPTYING | 14 | 34.54 | 34.54 (20.42–58.42) | |
DIABETIC RETINOPATHY | 6 | 33.33 | 33.33 (14.95–74.31) | |
THYROID MASS | 6 | 32.37 | 32.37 (14.52–72.17) | |
LIPASE INCREASED | 11 | 26.81 | 26.81 (14.83–48.49) |
Note: a, number of cases with available; PT, preferred term.